Financing with new investorI wasn't sure I liked the dilution at first but then I looked into Venbio select advisor.
got this from their website.
"We focus principally in securities of publicly traded biotechnology companies, and selectively in late-stage private thereputic companies often in advance of an exit. ( M&A,IPO)"
https://www.venbio.com/pubmarkets.html
so then I thought about the positives.
- enough cash to get to approval, this will help negotiations if Fennec decides to partner or sell
- Venbio's experience and support to exit will be very valuable
- possibility of listing on Nasdaq now that the criteria is satisfied
- increased visibility should help the stock price.
Rosty has done a fantastic job of keeping the share count down and not diluting the shareholders. I think all in all this financing is very positive.
Any thoughts?
i feel like I have been talking to myself on this board lately